Immune Pharmaceuticals Inc(IMNP)股吧_Immune Pharmaceuticals Inc怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
3508	0	Current report, items 1.03, 5.02, and 9.01	Immune Pharmaceu资讯	03-09 06:08
3295	0	Current report, items 2.04 and 9.01	Immune Pharmaceu资讯	02-15 06:15
3271	0	Prospectus [Rule 424(b)(4)]	Immune Pharmaceu资讯	02-08 07:26
3358	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	01-18 03:10
3358	0	Notification filed by national security exchange to report the removal from lis	Immune Pharmaceu资讯	01-08 11:34
3575	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	12-20 07:00
3433	0	Current report, items 5.03, 5.07, and 9.01	Immune Pharmaceu资讯	12-20 06:00
3249	0	Current report, items 8.01 and 9.01	Immune Pharmaceu资讯	12-06 10:59
3314	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Immune Pharmaceu资讯	12-06 10:59
3341	0	Current report, items 8.01 and 9.01	Immune Pharmaceu资讯	11-29 06:58
3231	0	Current report, item 2.04	Immune Pharmaceu资讯	11-27 07:17
3283	0	General form for registration of securities under the Securities Act of 1933	Immune Pharmaceu资讯	11-22 10:35
3336	0	Initial statement of beneficial ownership of securities	Immune Pharmaceu资讯	11-20 11:37
3327	0	Quarterly report [Sections 13 or 15(d)]	Immune Pharmaceu资讯	11-15 09:55
3226	0	Other definitive proxy statements	Immune Pharmaceu资讯	11-09 05:36
3235	0	Other preliminary proxy statements	Immune Pharmaceu资讯	10-30 06:13
3273	0	Current report, item 3.01	Immune Pharmaceu资讯	10-23 05:21
3329	0	Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01	Immune Pharmaceu资讯	10-11 05:20
3563	0	Current report, items 1.01, 3.02, and 9.01	Immune Pharmaceu资讯	09-19 05:23
3458	0	Current report, item 5.02	Immune Pharmaceu资讯	09-11 04:20
2013	0	Current report, items 5.02 and 9.01	Immune Pharmaceu资讯	08-29 08:06
1755	0	Quarterly report [Sections 13 or 15(d)]	Immune Pharmaceu资讯	08-15 05:47
1624	0	怎么停牌了	Z紫晗Z	07-26 11:17
1830	0	Current report, items 3.01, 7.01, and 9.01	Immune Pharmaceu资讯	07-26 11:02
1765	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Immune Pharmaceu资讯	07-17 09:31
1808	0	Other definitive proxy statements	Immune Pharmaceu资讯	07-17 09:31
2000	0	Other preliminary proxy statements	Immune Pharmaceu资讯	06-30 07:58
1815	0	Current report, items 3.01, 7.01, and 9.01	Immune Pharmaceu资讯	06-09 02:35
702	0	Statement of changes in beneficial ownership of securities	Immune Pharmaceu资讯	05-23 12:00
1754	0	Statement of changes in beneficial ownership of securities	Immune Pharmaceu资讯	05-19 11:45
1743	0	Quarterly report [Sections 13 or 15(d)]	Immune Pharmaceu资讯	05-15 11:25
708	0	Current report, items 1.01, 3.02, and 9.01	Immune Pharmaceu资讯	05-14 12:00
1694	0	Current report, items 5.02, 7.01, 8.01, and 9.01	Immune Pharmaceu资讯	05-08 03:57
700	0	Annual report [Section 13 and 15(d), not S-K Item 405]	Immune Pharmaceu资讯	04-02 12:00
2233	0	Current report, items 5.07, 7.01, and 9.01	Immune Pharmaceu资讯	03-01 12:01
1993	0	Current report, items 5.07, 7.01, and 9.01	Immune Pharmaceu资讯	02-21 08:30
686	0	[Amend] Statement of acquisition of beneficial ownership by individuals	Immune Pharmaceu资讯	02-14 12:00
1758	0	Current report, items 7.01 and 9.01	Immune Pharmaceu资讯	02-13 04:18
2354	0	Current report, items 8.01 and 9.01	Immune Pharmaceu资讯	02-09 02:27
3076	0	Current report, items 8.01 and 9.01	Immune Pharmaceu资讯	01-27 02:49
2294	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	Immune Pharmaceu资讯	01-27 02:48
1532	0	Current report, items 7.01 and 9.01	Immune Pharmaceu资讯	01-10 10:46
1931	0	Other definitive proxy statements	Immune Pharmaceu资讯	12-19 07:07
1395	0	[Amend] Current report, items 4.01 and 9.01	Immune Pharmaceu资讯	12-15 03:59
1314	0	Current report, item 4.01	Immune Pharmaceu资讯	12-14 07:14
1182	0	Other preliminary proxy statements	Immune Pharmaceu资讯	12-09 07:27
703	0	Current report, item 3.01	Immune Pharmaceu资讯	12-06 12:00
1301	0	Current report, items 5.02 and 9.01	Immune Pharmaceu资讯	12-05 02:08
1380	0	Current report, items 3.01 and 5.02	Immune Pharmaceu资讯	11-28 03:32
1335	0	Current report, items 8.01 and 9.01	Immune Pharmaceu资讯	11-18 05:44
691	0	Quarterly report [Sections 13 or 15(d)]	Immune Pharmaceu资讯	11-14 12:00
1842	0	Current report, items 5.03 and 9.01	Immune Pharmaceu资讯	10-26 04:47
1406	0	Current report, items 8.01 and 9.01	Immune Pharmaceu资讯	10-24 01:57
1619	0	Prospectus [Rule 424(b)(4)]	Immune Pharmaceu资讯	10-21 04:30
1570	0	Registration adding securities to prior Form S-1 registration [Rule 462(b)]	Immune Pharmaceu资讯	10-20 04:05
1413	0	Notice of Effectiveness	Immune Pharmaceu资讯	10-19 09:31
1344	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	10-18 06:43
1358	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	10-17 03:52
1450	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	10-12 08:13
692	0	Current report, items 7.01 and 9.01	Immune Pharmaceu资讯	10-03 12:00
1221	0	Initial statement of beneficial ownership of securities	Immune Pharmaceu资讯	09-19 10:58
1204	0	Statement of changes in beneficial ownership of securities	Immune Pharmaceu资讯	09-19 10:58
1180	0	General form for registration of securities under the Securities Act of 1933	Immune Pharmaceu资讯	09-11 10:32
1650	0	Current report, item 8.01	Immune Pharmaceu资讯	09-09 05:37
1699	0	Current report, items 3.01 and 9.01	Immune Pharmaceu资讯	08-30 05:58
1301	0	Current report, items 1.01, 3.02, and 9.01	Immune Pharmaceu资讯	08-24 09:55
1387	0	Quarterly report [Sections 13 or 15(d)]	Immune Pharmaceu资讯	08-22 08:41
1326	0	Current report, items 5.02 and 9.01	Immune Pharmaceu资讯	08-19 09:40
1449	2	Notification of inability to timely file Form 10-Q or 10-QSB	Immune Pharmaceu资讯	08-15 04:40
1339	0	Notice of Effectiveness	Immune Pharmaceu资讯	08-04 06:56
1305	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	08-02 05:19
1035	0	[Cover]SEC-generated letter	Immune Pharmaceu资讯	08-01 12:00
1069	0	[Cover]Correspondence	Immune Pharmaceu资讯	08-01 12:00
1096	0	[Cover]Correspondence	Immune Pharmaceu资讯	08-01 12:00
1447	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	07-29 09:42
1158	0	Statement of changes in beneficial ownership of securities	Immune Pharmaceu资讯	07-21 09:22
1332	0	Current report, item 1.01	Immune Pharmaceu资讯	07-19 06:14
1301	0	[Amend] General form for registration of securities under the Securities Act of	Immune Pharmaceu资讯	07-19 05:31
1403	0	Current report, items 1.01, 8.01, and 9.01	Immune Pharmaceu资讯	07-13 02:07

emytylist